HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC Raises ‘Grave Concerns’ About China’s Cosmetic Regs, Possible WHO Treaty Noncompliance

Executive Summary

Foreign cosmetic product manufacturers may avoid the Chinese market if burdensome registration requirements aren’t modified and fairness issues addressed, the trade association says in comments to the Office of the US Trade Representative.

You may also be interested in...



PCPC’s International Efforts Focused On EU Microplastics Reg, China's CSAR Rollout

Francine Lamoriello, executive vice president of global strategies at the Personal Care Products Council, provided an overview of the group’s international activities at its 2022 Leadership Summit in Washington.

China’s Cosmetic Animal-Testing Exemption 'Not Yet A Terribly Meaningful Solution' – PCPC

The Personal Care Products Council’s Francine Lamoriello, EVP of global strategies, discusses shortcomings of a proposed animal-testing exemption for imported general cosmetics under a key implementing regulation drafted for China’s new cosmetics oversight framework.

PCPC Expects Rapid-Fire Implementing Measures Following China’s CSAR Drop

China’s newly adopted Cosmetics Supervision and Administration Regulation could mean less animal testing and speedier approval of new ingredients, according to Francine Lamoriello of the Personal Care Products Council. Coming implementing regulations, standards and guidances should help to provide needed clarity, she says.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153125

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel